Vascular Perfusion Solutions – Winners of 2023 BioFest Invest Event

We would like to congratulate Vascular Perfusion Solutions, Inc. on their win at the 3rd annual BioFest Invest Event . This event is hosted by BiomedSA, and as a result of their win, Vascular Perfusion Solutions will be receiving an annual subscription to PatWorld.

Isabella Cano – Research Engineer at VPS

PatWorld is a professional patent database for R&D that provides users with access to millions of patents from around the world. With this subscription, Vascular Perfusion Solutions will have access to the latest information in their field and be able to stay ahead of the competition. We are excited for them as they embark on this new journey with PatWorld!

Vascular Perfusion Solutions, Inc. is a medical technology company based in San Antonio, Texas. They are developing the VP.S ENCORE® designed to have a significant impact on patients awaiting lifesaving or life-altering transplant surgeries by extending the viability of organs outside the body, and by extending the time for transport compared to traditional ice cooler technology. The goal in developing the VP.S ENCORE® includes the ability to expand the donor organ pool, optimizing matching of the donor organs, and to minimize rejection. VPS believes that machine perfusion devices for preserving organs should be simple, portable, and accessible to all patients needing a lifesaving organ. Evidence-based science is the root of what they do, and they use science and engineering to provide simple, elegant, and effective solutions to preserving the life of organs beyond the standard of care.

On April 19th, Vascular Perfusion Solutions competed in the 3rd annual BioFest Invest Event hosted by BiomedSA. BioFest Invest is a pitch competition for Texas bioscience companies to present their life changing products to potential investors, network among the MedTech industry, and learn from industry professionals. VPS pitched among 13 other bioscience companies from the greater Texas area. VPS was represented by Research Engineer, Isabella Cano, who has been part of the team since June 2021. The pitch presented the impact of the lifesaving technology of the VP.S ENCORE® and its competitive advantages. Vascular Perfusion Solutions received the best pitch award among all the competitors and was awarded a prize package of $10,000, SBIR consulting, a marketing strategy consult, a press release, and a membership to PatWorld.


Isabella and the team at VPS were delighted to receive the prize from PatWorld. To ensure they could get the most out of the platform, we delivered a personalised demo that was tailored to their specific needs. This gave them an in-depth look at how PatWorld can help them with R&D activities and how it can be used to improve their processes.

If you’re interested in learning more about PatWorld, you can sign up for a demo at https://calendly.com/patworld/demo. By taking advantage of this offer, you will be able to explore all the features and functions of the platform and see first-hand how it can benefit your business.

We at PatWorld are also experts in providing Patentability, Freedom To Operate (FTO), Patent Busting, State of the Art, and Patent Mapping searches. Need help in deciding which search you need? Email: [email protected] for information.

If you enjoy our content here, you’ll love the stuff we share on LinkedIn, follow us now. Not on LinkedIn?  Check out our other social media sites:

Twitter PatWorld Patent Database & Search Service (@PatWorlddata) / Twitter

Facebook PatWorld Patent Intelligence Platform & Research Services | Newport | Facebook

Instagram https://www.instagram.com/patworld__database/ 

PatWorld Global IP Research Services

Patent, Design, and Trademark Research Experts with a combined experience of over 100 years in Intellectual Property searching. Highly trained, dynamic in-house research teams specialising in a wide range of subject matter. All our analysts follow a training program developed by former IPO Examiners. Our teams are available to discuss any specific technical points regarding your search enquiries.